Gene · 5376
Papers3,310
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,310
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long term exposure of cigarette smoke condensate (CSC) mediates transcriptomic changes in normal human lung epithelial Beas-2b cells and protection by garlic compounds. | Food Chem Toxicol | 2023 | 36758788 | PubTator, text mining | PubMed |
| Friends or foes: The mononuclear phagocyte system in ischemic stroke. | Brain Pathol | 2023 | 36755470 | PubTator, text mining | PubMed |
| An Unusual Case of Hereditary Neuropathy With Liability to Pressure Palsy: A Diagnostic Challenge. | Cureus | 2023 | 36741649 | PubTator, text mining | PubMed |
| The phenotypic spectrum of pathogenic ATP1A1 variants expands: the novel p.P600R substitution causes demyelinating Charcot-Marie-Tooth disease. | J Neurol | 2023 | 36738336 | PubTator, text mining | PubMed |
| Multifaceted nanoparticles: emerging mechanisms and therapies in neurodegenerative diseases. | Brain | 2023 | 36729638 | PubTator, text mining | PubMed |
| Schwann cell-matrix coated PCL-MWCNT multifunctional nanofibrous scaffolds for neural regeneration. | RSC Adv | 2023 | 36712918 | PubTator, text mining | PubMed |
| Chronic escitalopram in healthy volunteers has specific effects on reinforcement sensitivity: a double-blind, placebo-controlled semi-randomised study. | Neuropsychopharmacology | 2023 | 36683090 | PubTator, text mining | PubMed |
| MARS1 mutations linked to familial trigeminal neuralgia via the integrated stress response. | J Headache Pain | 2023 | 36641423 | PubTator, text mining | PubMed |
| Anti-LGI4 Antibody Is a Novel Juxtaparanodal Autoantibody for Chronic Inflammatory Demyelinating Polyneuropathy. | Neurol Neuroimmunol Neuroinflamm | 2023 | 36631269 | PubTator, text mining | PubMed |
| Electroceutical approach ameliorates intracellular PMP22 aggregation and promotes pro-myelinating pathways in a CMT1A in vitro model. | Biosens Bioelectron | 2023 | 36630746 | PubTator, text mining | PubMed |
| Metabolic disorder and intestinal microflora dysbiosis in chronic inflammatory demyelinating polyradiculoneuropathy. | Cell Biosci | 2023 | 36627678 | PubTator, text mining | PubMed |
| The intestinal microenvironment shapes macrophage and dendritic cell identity and function. | Immunol Lett | 2023 | 36623708 | PubTator, text mining | PubMed |
| Treatment of Charcot-Marie-Tooth neuropathies. | Rev Neurol (Paris) | 2023 | 36588067 | PubTator, text mining | PubMed |
| How T118M peripheral myelin protein 22 predisposes humans to Charcot-Marie-Tooth disease. | J Biol Chem | 2023 | 36581210 | PubTator, text mining | PubMed |
| CMT1A current gene therapy approaches and promising biomarkers. | Neural Regen Res | 2023 | 36571339 | PubTator, text mining | PubMed |
| Neuromodulation with transcutaneous spinal stimulation reveals different groups of motor profiles during robot-guided stepping in humans with incomplete spinal cord injury. | Exp Brain Res | 2023 | 36534141 | PubTator, text mining | PubMed |
| Task force Guideline of Brazilian Society of Otology ‒ hearing loss in children - Part I ‒ Evaluation. | Braz J Otorhinolaryngol | 2023 | 36529647 | PubTator, text mining | PubMed |
| Downregulation of PMP22 ameliorates myelin defects in iPSC-derived human organoid cultures of CMT1A. | Brain | 2023 | 36511878 | PubTator, text mining | PubMed |
| Prevalence and correlates of knowledge and practices regarding infection prevention and control, and triage in primary healthcare settings: A cross-sectional study in Bangladesh. | Infect Prev Pract | 2023 | 36478873 | PubTator, text mining | PubMed |
| Frequency, entity and determinants of fatigue in Charcot-Marie-Tooth disease. | Eur J Neurol | 2023 | 36458502 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5376/papers?page=20